I haven't bought for a while due to it trending down relentlessly but today it has reached a share price within 2c of where it traded on the day it listed. That's despite very positive trial results proving it works better than any other product on the market. Something that was not proven at the time of listing. They also now have a clear path to what is needed for FDA approval and importantly they also have now have access to pre FDA sales into the US. That will be a much larger market than the Australian pre approval market. So while it appears FDA approval has been pushed out by probably at least 6 months, much of the risk has been removed and the sp is no longer near $2 but back to where it was on listing. For those reasons, I bought another 40,000 shares today for under $20k. By comparison, 40,000 shares near the high would have cost over $80k. Happy to buy here and sit.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)